Loading...
XETR
H2A
Market cap243mUSD
Feb 26, Last price  
5.85EUR
Name

exceet Group SCA

Chart & Performance

D1W1MN
XETR:H2A chart
P/E
P/S
55.27
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
-20.37%
Revenues
4m
+200.52%
00170,476,000188,752,000190,765,000185,312,000181,592,000135,322,000143,383,00041,535,00043,657,00045,446,0001,280,5003,848,100
Net income
-4m
L
0014,706,0003,443,0007,540,0004,402,000-1,167,000-31,403,000-11,015,00052,400,0002,520,0003,114,00087,053,000-3,872,000
CFO
-4m
L
0018,890,0001,529,00018,255,00012,101,0009,078,000-2,130,0008,291,0002,279,0005,436,0007,447,0004,080,000-4,077,000
Dividend
Jun 26, 20201.75 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Presently, exceet Group SCA conducts minimal significant operations. The entity primarily adopts an opportunistic investment stance, characterized by the absence of a fixed or pre-determined strategy. Historically, its activities included supplying products and solutions to both the healthcare and industrial markets. The company, established in 2009, is headquartered in Grevenmacher, Luxembourg, and operates as a subordinate entity of White Elephant S.à r.l.
IPO date
Feb 04, 2010
Employees
Domiciled in
LU
Incorporated in
LU

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT